Mesa Laboratories, Inc.
MLABNASDAQTechnology● Active
$108.46
+$4.57(+4.40%)
Market Cap$599233908
P/E Ratio—
52W High$111.29
52W Low$55.45
Mesa Laboratories, Inc. (MLAB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MLAB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.25B | $0.24B | $0.22B | $0.22B | $0.18B |
| Cost of Revenue | $0.09B | $0.09B | $0.08B | $0.09B | $0.08B |
| Gross Profit | $0.16B | $0.15B | $0.13B | $0.13B | $0.11B |
| Gross Margin %(computed) | 63.53% | 62.61% | 61.64% | 61.02% | 59.18% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.02B | $0.02B | $0.02B | $0.02B |
| G&A Expenses | $0.08B | $0.07B | $0.07B | $0.07B | $0.06B |
| Total Operating Expenses | $0.14B | $0.13B | $0.41B | $0.13B | $0.10B |
| Operating Income | $0.02B | $0.02B | ($0.27B) | $0.00B | $0.00B |
| Operating Margin %(computed) | 7.43% | 6.78% | -125.85% | 1.52% | 2.55% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | $0.01B | ($0.28B) | ($0.00B) | $0.00B |
| Income Tax Expense | $0.01B | $0.01B | ($0.02B) | ($0.00B) | $0.00B |
| Net Income | $0.01B | ($0.00B) | ($0.25B) | $0.00B | $0.00B |
| Net Margin %(computed) | 2.69% | -0.82% | -117.60% | 0.42% | 1.01% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.22 | $-0.36 | $-47.20 | $0.17 | $0.36 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | $0.04B | $0.04B | ($0.24B) | $0.04B | $0.03B |
| EBITDA Margin %(computed) | 16.77% | 17.57% | -110.26% | 17.12% | 17.65% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Mesa Laboratories, Inc. data
About Mesa Laboratories, Inc. (MLAB) Income Statement
Mesa Laboratories, Inc. (MLAB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, MLAB reported revenue of $0.25B, gross profit of $0.16B (gross margin 63.53%), and net income of $0.01B — a net profit margin of 2.69%.
Frequently asked questions
MLAB · 4 questionsMesa Laboratories, Inc. (MLAB) reported revenue of $0.25B for 2026, up 3.4% year-over-year.
MLAB revenueMLAB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08